Research & Development News
European Consumers Seeking Health and Pharmaceutical Information
European consumers have been a long-neglected piece of the strategic puzzle for most marketers at health and pharmaceutical companies. Yet signs increasingly point to the degree to which European consumers are, in fact, researching health information and treatment options, and ultimately taking action as a result of those information searches. Life Science Platform Promotes True Scientific Collaboration
Collexis (OTCBB: CLXS), a leading developer of high-definition search and discovery software, and their German partner, SyynX Solutions, announced they will preview a new life sciences social networking site to representatives from global book publishing and multimedia companies at the Frankfurt Book Fair in Frankfurt, Germany. Integrated RSS Management Solution Simplifies Information Management and Delivery
Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, announced the launch of Enterprise Alert Manager, an integrated RSS management and collaboration solution designed to simplify information distribution across an organization by allowing for easy deployment while reducing email load and network strain. European Medicines Agency recommends restricted use of nimesulide-containing medicinal products
Finalising a review of the liver safety of systemic formulations of medicines containing nimesulide, the European Medicines Agency (EMEA) has concluded that the benefits of these medicines outweigh their risks, but that there is a need to limit the duration of use and to restrict their use to ensure that the risk of patients developing liver problems is kept to a minimum. New EU Project to Develop a Novel Pandemic Influenza Vaccine
International experts in the field of human virus research and vaccine development have teamed up to develop a pandemic influenza vaccine. The aim of the EU-funded FluVac project is to conduct research and development (R&D) into a novel pandemic influenza vaccine that could be used as a potential emergency vaccination. The project partners, recently awarded a grant of €3.5 million under the EU's Sixth Framework Programme (FP6), plan to deliver a prototype vaccine within four years. Launch of a broad public debate on the future of pharmaceuticals for human use in Europe
The Commission launches a public consultation on the future of pharmaceuticals for human use in Europe. The pharmaceutical sector has been and remains a key strategic sector in Europe. The future of this sector is a crucial matter for the EU. More Pharma News ...
Business & Industry
- Pfizer and BioNTech achieve first authorization in the world for a vaccine to combat COVID-19
- Moderna announces primary efficacy analysis in Phase 3 COVE study for its COVID-19 vaccine candidate and filing today with U.S. FDA for Emergency Use Authorization
- Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives interim authorization from Health Canada as a treatment for COVID-19
- AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
- Pfizer and BioNTech to submit Emergency Use Authorization request today to the U.S. FDA for COVID-19 vaccine
Research & Development
- Study finds metformin reduced COVID-19 death risks in women
- KU Leuven vaccine candidate protects against COVID-19 and yellow fever
- UK medicines regulator gives approval for first UK COVID-19 vaccine
- Predict cellular drug targets against COVID-19
- Doctors use existing treatment earlier to save the lives of COVID-19 patients
- European Commission approves contract with Moderna to ensure access to a potential vaccine
- New therapy for flu may help in fight against COVID-19
Conferences & Events
- CPhI Worldwide to return in 2021
- Reuters Events' Cell & Gene Therapy USA
- Total health: Build a better healthcare system
- Don't fall for the 'next best action' trap
- Locking down shape-shifting spike protein aids development of COVID-19 vaccine
- COVID-19 vaccine innovation could dramatically speed up worldwide production
- Wearable Injectors and Connected Devices Conference 2020
Regulatory Affairs
- EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2
- EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine
- FDA authorizes monoclonal antibodies for treatment of COVID-19
- FDA approves first treatment for COVID-19
- EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation